↓ Skip to main content

PLOS

Estimating the Influenza Vaccine Effectiveness against Medically Attended Influenza in Clinical Settings: A Hospital-Based Case-Control Study with a Rapid Diagnostic Test in Japan

Overview of attention for article published in PLOS ONE, January 2013
Altmetric Badge

Mentioned by

twitter
2 X users
facebook
1 Facebook page

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
43 Mendeley
Title
Estimating the Influenza Vaccine Effectiveness against Medically Attended Influenza in Clinical Settings: A Hospital-Based Case-Control Study with a Rapid Diagnostic Test in Japan
Published in
PLOS ONE, January 2013
DOI 10.1371/journal.pone.0052103
Pubmed ID
Authors

Motoi Suzuki, Hiroyuki Yoshimine, Yoshitaka Harada, Naho Tsuchiya, Ikumi Shimada, Koya Ariyoshi, Kenichiro Inoue

Abstract

Influenza vaccine effectiveness (VE) studies are usually conducted by specialized agencies and require time and resources. The objective of this study was to estimate the influenza VE against medically attended influenza using a test-negative case-control design with rapid influenza diagnostic tests (RIDT) in a clinical setting.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 2%
Unknown 42 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 19%
Student > Master 8 19%
Researcher 7 16%
Other 5 12%
Student > Bachelor 3 7%
Other 5 12%
Unknown 7 16%
Readers by discipline Count As %
Medicine and Dentistry 19 44%
Agricultural and Biological Sciences 5 12%
Social Sciences 3 7%
Mathematics 1 2%
Biochemistry, Genetics and Molecular Biology 1 2%
Other 5 12%
Unknown 9 21%